Abstract
ObjectivesThe aim of the present study is to analyze preclinical and clinical data on the performance of the currently US Food and Drug Administration (FDA)-approved microwave ablation (MWA) systems.MethodsA review of the literature, published between January 1, 2005, and December 31, 2016, on seven FDA-approved MWA systems, was conducted. Ratio of ablation zone volume to applied energy R(AZ:E) and sphericity indices were calculated for ex vivo and in vivo experiments.ResultsThirty-four studies with ex vivo, in vivo, and clinical data were summarized. In total, 14 studies reporting data on ablation zone volume and applied energy were included for comparison R(AZ:E). A significant correlation between volume and energy was found for the ex vivo experiments (r=0.85, p
Original language | English |
---|---|
Pages (from-to) | 4026-4035 |
Number of pages | 10 |
Journal | European Radiology |
Volume | 29 |
Issue number | 8 |
Early online date | 30-Nov-2018 |
DOIs | |
Publication status | Published - Aug-2019 |
Keywords
- Microwaves
- Ablation techniques
- Electromagnetic radiation
- Tumor volume
- Liver diseases
- EX-VIVO BOVINE
- VENOUS-BLOOD FLOW
- IN-VIVO
- THERMOSPHERE ABLATION
- HEPATOCELLULAR-CARCINOMA
- RADIOFREQUENCY ABLATION
- REPORTING CRITERIA
- THERMAL ABLATION
- DEVICES
- ENERGY